期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

大肠癌淋巴靶向化疗的研究进展 被引量：1

The progress of lymph node-targeted chemotherapy in colorectal carcinomas
下载PDF
导出
摘要 大肠癌常规化疗疗效不尽人意。淋巴靶向化疗能有效防治大肠癌淋巴道转移 ,降低术后复发 ,改善预后 ,有着广阔发展前景。现就大肠癌淋巴靶向化疗的概念、临床意义、常用剂型。
作者 张守亮
机构地区 江西医学院第二附属医院普外二科
出处 《国外医学（肿瘤学分册）》 2003年第5期381-384,共4页 Foreign Medical Sciences (Cancer Section)
关键词 大肠癌 淋巴靶向化疗 研究进展 防治 预后
分类号 R735.34 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomlsed trials [ J ]. BMJ, 2002, 324(7341) : 813.
  • 2Toma A, Hagiwara A, Otsuji E, et al. Detection of sentinel lymphatic region with activated carbon particles in lymph node dissection for colorectal cancer[ J ]. Gan To Kagaku Ryoho, 2002, 29 ( 12 ) :2291-2293.
  • 3Hagiwara A, Torii T, Sawai K, et al. Local injection of anti-cancer drugs hound to carixm particles for early gastric cancer- a pilot study [J]. Hepatogastroenterology, 2000, 47(32): 575-578.
  • 4Kiyokawa H, Igawa Y, Muraishi O, et al. Distribution of doxorubicin in the bladder wall and regional lymph nodes after bladder submucosal injection of liposcxnal doxorubicin in the dog[J]. J Urol, 1999,161(2) : 665-667.
  • 5Akamo Y, Mizuno I, Takeyama H, et al. Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric cancer[J ]. Can To Kagaku Ryoho, 1997, 24(12): 1712-1714.
  • 6Phillips WT, Klipper R, Goins B. Novel method of greatly enhanced delivery of lipostmaea to lymph nodes[ J ]. J Pharmacol Exp Ther, 2000, 295(1): 309-313.
  • 7Fundaro A, CavaUi R, Bargoni A, et al. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i. v. administration to rats[J ]. Pharmacol Res, 2000, 42(4): 337-343.
  • 8Yang S, Zhu J, Lu Y, et al. Body distribution of camptothecin solid lipid ~icles after oral administration [ J ]. Pharmacol Res, 1999, 16(5): 751-756.
  • 9Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system[J]. Adv Drug Deliv Rev, 2001, 47(1): 55-64.
  • 10Shafik A, El Memawy W, El Sibai O. Anal submucce, al injection: a novel modality for the treatment of advanced rectal cancer[J]. Eur J Surg Oncol, 1999, 25(1): 76-81.

同被引文献24

  • 1O'Connell M J,Laurie J A,Kahn M,et al.Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer[J].J Clin Oncol,1998,16(1):295-300.
  • 2de Gramont A,Boaset J F,Milan C,et al.Randomized trial comparing monthly lowdose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer[J].J Clin Oncol,1997,15(2):808-815.
  • 3de Gramont A,Figer M,Homerin M,et al.Leucovorin and fluorouracil with or without Oxaliplatin as first-line treatment in advanced colorectal cancer[J].J Clin Oncol,2000,18:2938-2947.
  • 4Saltz L B,Cox J V,Blanke C,et al.Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer[J].Nengl J Med,2000,343:905-914.
  • 5Liver Infusion Meta-analysis Group.Portal vein chemotherapy for colorectal cancer:a meta-analysis of 4 000 patients in 10 studies[J].J Natl Cancer Inst,1997,89(7):497-505.
  • 6Funami Y,Tokumo H M,Yauchi H,et al.Prognostic value of peritoneal lavage cytology and chemotherapy daring surgery for advanced gastric cancer[J].Int Surg,1999,84(3):220-224.
  • 7Ohtsu A,Baba H,Sakata Y,et al.Phase Ⅱ study of S-1,a novel oral fluoropyrimidine derivative in patients with metastatic colorectal cancer[J].BrJ Cancer,2000,83:141-145.
  • 8Miwa M,Ura M,Nishida M,et al.Design of a novel oral fluoropyrimidine carbamate,capecitabine,which generates 5-fluorouracil selectively in tumours by enzymesconcentrated in human liver and cancer tissue[J].Eur J Cancer,1998,34(8):1274-1281.
  • 9Miyadera K,Sumizawa T,Haraguchi M,et al.Role ofthymidine phosphorylase activity in the angiogenic effect of platelet derived endothelial cell growth factor/thymidine phosphorylase[J].Cancer Res,1995,55(8):1687-1690.
  • 10Hoff P M,Ansari R,Batist G,et al.Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer.Results of a randomized phase Ⅲ study[J].J Clin Oncol,2001,19:2282-2292.

引证文献1

二级引证文献9

国外医学（肿瘤学分册）
2003年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部